Phosphorylation of the p53 tumor suppressor protein is likely to play an important role in regulating its activity. To study the regulatory role of potential phosphorylation sites within the N-terminal transactivation domain of human p53 (hp53), a series of p53 serine mutants were evaluated for transcriptional transactivation and sequence speci®c DNA binding. The role of these mutations in regulating p53-mediated growth suppression and programmed cell death was examined. This mutational analysis comprised serine residues located at positions 6, 9, 15, 20, 33 and 37 of human p53. Substitution of serine for alanine, either at individual residues or at all six residues together, did not aect the suppression of cell growth and cell transformation, or the ability to bind DNA speci®cally and to transactivate dierent promoters, nor did it alter p53 expression. However, the ability of p53 to induce apoptosis was impaired by speci®c serine substitutions. Mutations in all six N-terminal serines together reduced the apoptotic activity of p53 in H1299 cells by 50%. Analysis of individual mutants revealed that mutations in serine 15 and 20 are primarily responsible for this impairment. Our results suggest that these serines play a role in the regulation of p53-mediated apoptosis.
Introduction p53 is a cellular phosphoprotein which functions as a tumor suppressor. The biological eects of the p53 protein are largely due to sequence-speci®c binding to DNA and transcriptional activation of certain genes important for cell cycle regulation and programmed cell death (apoptosis). The decision of a cell to undergo viable growth arrest, or apoptosis in response to p53 activation, depends on the cell type and the microenvironment (Gottlieb and Oren, 1996; Bates and Vousden, 1996; Levine, 1997) . Mutation of the p53 gene is the most common speci®c genetic event detected in dierent types of human malignancies (Velculescu and El-Deiry, 1996) . Most of the mutations are localized within the central domain of the protein, a region responsible for speci®c DNA binding.
Naturally occurring mutants of p53 stimulate tumor growth and are unable to bind speci®cally to DNA and to induce apoptosis (e.g. Unger et al., 1993; .
Of the many biochemical functions of p53, the major function is to transactivate dierent target genes. The activation domain is located at the N-terminus of the protein . This domain can interact with components of the basal transcription machinery (Lu and Levine, 1995) and promote the transcription of genes containing p53 binding sites. A variety of p53-responsive genes have been identi®ed, including genes mediating growth arrest (p21
), apoptosis (IGF-BP3, CD95/Fas, bax and PIG3), and regulatory genes (e.g. mdm2) (reviewed in Wyllie, 1997; Levine, 1997; Polyak et al., 1997) .
One of the mechanisms that may be involved in the regulation of p53 function is phosphorylation (Meek, 1998) . Phosphorylation has been shown to positively regulate the transcriptional activity of many transcription factors including c-jun, CREB and NF-IL6/LAP (Gonzalez and Montminy, 1989; Smeal et al., 1991; Trautwein et al., 1993) and to regulate the stability of other proteins such as c-jun and NF-kB (Fuchs et al., 1996; Lin et al., 1996) . The p53 protein is phosphorylated at several serine residues within the amino and carboxy terminal regions by a number of cellular kinases (Steegenga et al., 1996; Milczarek et al., 1997) . The carboxy terminal kinases have been shown to enhance the in vitro sequence-speci®c DNA binding capability of p53 (Hupp et al., 1992; Takenaka et al., 1995; Wang and Prives 1995; Lu et al., 1997) . There are several kinases that phosphorylate at the Cterminus of human p53 (hp53). Serine (Ser) 315 of hp53 is a target for phosphorylation by p34cdc2 kinase and by cyclin dependent kinase 2 (Addison et al., 1990; Bischo et al., 1990; Wang and Prives, 1995) . Serine 392 undergoes phosphorylation in vivo, and was shown to be phosphorylated in vitro by puri®ed casein kinase II (Meek et al., 1990) . The eects of substitution of Ser 392 with alanine on the transcriptional activity of p53 and on its ability to suppress cell growth were found to be cell type dependent phosphorylation sites (Milne et al., 1992; Fiscella et al., 1994; Hao et al., 1996; Hall et al., 1996) . At the amino terminus several phosphorylation sites have been identi®ed. Ser 15 and 37 have been shown to be phosphorylated by DNA-dependent protein kinase (DNA-PK) (Lees Miller et al., 1992) and Ser 33 by CDK7-cyclin H-p36 (also referred as CAK, cyclin dependent kinase activating kinase, Ko et al., 1997) . Ser 15 can also undergo phosphorylation by the ATM protein, whose kinase activity is being stimulated by ionizing radiation (Banin et al., 1998; Canman et al., 1998) . So far, relatively little is known about the role of the N-terminus in the regulation of p53 activity. Several studies were carried out with dierent serine mutants at the N-terminus analysing the role of these sites in sequence speci®c transactivation and growth suppression by p53 (Fuchs et al., 1995; Mayr et al., 1995; Lohrum and Scheidtmann, 1996) . Variations in the eects of those mutants were observed indicating dierences in the cellular systems and expression of p53 proteins that were used. Recently it has been shown that DNA damage, caused by ionizing or ultraviolet irradiation, induces the phosphorylation of two serines within the ®rst 24 amino acids of p53, one of which is Ser 15 (Siliciano et al., 1997) .
In this study we have investigated the role of Nterminal serine phosphorylation sites in the regulation of p53 functions. These include the ability of p53 to bind speci®cally to DNA and to transactivate reporter genes, to suppress colony growth and cell transformation, and to induce apoptosis. We report that substitution of the dierent serines does not aect the ability of p53 to bind speci®cally to a consensus p53 binding DNA sequence and transcriptionally activate dierent promoters, nor does it aect the levels of p53 expression to a signi®cant extent. Importantly, substitution of all six N-terminal serine residues to alanine reduced the ability of p53 to induce apoptosis by about 50%. Speci®c analysis of the individual serine residues revealed that this eect was contributed mainly by the substitutions at serines 15 and 20.
Results

Transcriptional activity of serine mutants within the transactivation domain of p53
We analysed the eect of mutations in potential phosphorylation sites within the N-terminal region of p53 on its transactivation function. Expression plasmids were constructed containing individual mutations aecting serine residues at positions 6, 9, 15, 20, 33 and 37 of hp53. These mutations resulted in the substitution of serines to alanine (Ala, a nonphosphorylatable amino acid) or to aspartate (Asp, a negatively charged amino acid that may mimic a phosphorylated state) on the background of the mammalian expression vector pRC/CMV. Plasmids expressing the dierent p53 mutants were transfected into the p53-negative human lung cancer cell lines H358 and H1299. Mutant p53 proteins were tested for their ability to transactivate a p53 responsive CAT reporter plasmid, p6FSVCAT, which contains six copies of a p53 binding motif upstream of the promoter (Mietz et al., 1992) . H358 cells were transfected with wt p53 or with each of the serine mutants. Thirty-six hours post-transfection, cell extracts were prepared and CAT activity was measured. Each of the individual serine mutants, whether substituted for alanine or for aspartate, transactivated the p53-dependent reporter to levels similar to that of wt p53 (Figure 1a) . Furthermore, even the p53 mutant in which all six N-terminal serine residues were mutated to alanine (p53all Ala) or to aspartate (p53all Asp) retained full transactivation ability for this reporter (Figure 1b) .
Since the analysis of a single CAT reporter may not be sensitive enough to detect moderate dierences in the transcriptional activity of the dierent serine mutants, the more sensitive luciferase assay was used to measure the transactivation of several physiological p53-responsive promoters. H1299 cells were transfected with wt p53 or serine mutants along with a reporter plasmid containing the ®re¯y luciferase gene under the control of the cyclin G promoter (Zauberman et al., 1995) . Twenty-four hours post-transfection, luciferase activity was measured in extracts derived from the transfected cells. The activity of most mutants was similar to that of wt p53, while that of Ala 6 and Ala 9 appeared slightly elevated and p53Ala 15 exhibited fairly reduced transcriptional activity ( Figure 1c ). The same mutants were screened for their ability to transactivate the bax promoter. Using this reporter, the transcriptional activity of most mutants was similar to that of wt p53, with the exception of p53Ala 33 and p53all Ala whose activity was moderately elevated (Figure 1d ). Thus, it appears that substitution of serines within the transactivation domain of p53 does not have a signi®cant eect on its transcriptional activity.
DNA binding activity of N-terminal serine mutants
We next tested whether certain serine substitutions may aect the ability of p53 to bind speci®cally to DNA. For this purpose, the dierent serine mutants were analysed for binding to an oligonucleotide containing a p53 consensus sequence, p53CON (Funk et al., 1992) , in the presence or absence of the anti-p53 monoclonal antibody PAb1801. H358 cells were transfected with wt p53 or dierent serine mutants, and 36 h later a nuclear extract was prepared from each transfected population. A speci®c retarded band was observed in extracts from cells transfected with wt p53, but not in extracts from cells transfected with either the empty vector plasmid, or with the p53Gln179 mutant ( Figure  2 ). The retarded band could be supershifted by the PAb1801 antibody. Each of the serine mutants, substituted with either alanine or aspartate, bound the oligonucleotide probes, and in each case the binding could be supershifted with PAb1801. Similarly, mutation of all six serines to alanines did not abolish speci®c DNA binding. The binding activities of most serine mutants were slightly reduced relative to wt p53, while p53Ala33 exhibited elevated binding. These dierences in binding activity probably re¯ect variations in protein concentration, as suggested by inspection of the non-speci®c bands. Therefore, the serine mutants within the N-terminal transactivation domain of p53 retain the ability to bind speci®cally to DNA.
p53 serine mutants can suppress colony outgrowth
The anti-proliferative potential of the various serine mutants was determined in a colony suppression assay, using H358 cells. Cells were transfected with the expression vectors expressing wt or mutant p53 together with the neomycin-resistance gene. Twentyfour hours post-transfection, cells were subjected to G418 selection, and two weeks later the number of colonies was counted. Only a few colonies grew in the presence of wt p53 (2%), whereas many colonies were observed in the presence of vector alone or with the p53Gln179 mutant. Each serine mutant suppressed colony growth to levels (1 ± 7%) comparable to that of wt p53 (Table 1) . Thus, under these experimental conditions mutations in the N-terminal serine residues do not aect the ability of p53 to suppress colony growth.
p53 serine mutants can suppress oncogene-mediated cell transformation
We have previously shown that the transactivation function of p53, although not absolutely required, contributes to suppression of cell transformation (Unger et al., 1993) . Moreover, in several p53 mutants the transcriptional activity and the transformation suppression activity have been dissociated (Crook et al., 1994) . Therefore, we examined the ability of the dierent serine mutants to suppress cell transformation. Primary rat embryo ®broblasts (REF) were transfected with wt p53, p53Gln179 mutant, or the dierent serine mutants of p53 together with either mutant ras alone or ras plus adenovirus E1A. Transformed foci were counted 2 weeks after the transfection. As expected, wt p53 suppressed focus formation induced by ras plus E1A, while p53Gln179 enhanced focus formation ( Table 2 ). Suppression of cell transformation by each of the Ser mutants was similar to that by wt p53. These results are consistent with a previous study demonstrating the ability of murine p53 mutated at Ser 9, 18 and 37, expressed under a cytomegalovirus (CMV) promoter, to suppress cell transformation by ras plus E1A (Mayr et al., 1995) . However, combinations of two or three serine mutations, under the expression of the Moloney sarcoma virus promoter, led to a decreased suppression ability (Mayr et al., 1995) . p53Ala 15 and p53Ala 20 have impaired apoptotic activity p53 can induce apoptosis by multiple mechanisms, including transcription-dependent and independent pathways (reviewed in Vogt Sionov and Haupt, 1998) . However, both the mechanisms and the regulation of p53-mediated apoptosis are poorly de®ned. Therefore, we decided to examine the role of serine phosphorylation in the apoptotic activity of p53, as measured by a transient transfection assay (Haupt et al., 1995) . H1299 cells were transiently transfected with plasmids expressing either wt p53, or the various serine mutants. Forty-eight hours post-transfection cells were collected, ®xed and stained for p53 using a mixture of anti-p53 speci®c monoclonal antibodies DO-1 and PAb1801, followed by binding to an FITC-conjugated secondary antibody. Cells were then analysed by¯ow cytometry (Haupt et al., 1995) . The transfected cells exhibit high levels of¯uorescent intensity, while the non-transfected cells have low¯uorescent intensity. The two sub-populations were analysed separately, and Figure 2 DNA binding activity of p53 serine mutants. H358 cells were transfected with the indicated p53 expression plasmids (6 mg) using lipofection. Nuclear extracts were subjected to gel shift analysis using a radiolabeled oligonucleotide probe of the p53 binding sequence (CON; Funk et al., 1992) . To half of the samples p53 monoclonal antibody PAb1801 was added to the nuclear extracts along with the labeled oligonucleotide probe (+). The arrow indicated the position of the p53-speci®c band. The two other bands are not p53 dependent, since they appear in all transfected extracts, including from cells transfected with vector alone (Figure 3 ; Haupt et al., 1995) . Cells with DNA content of less than 2N (referred to as Sub-G1) are considered apoptotic (Darzynkiewicz et al., 1992) . This transient apoptosis assay was used to measure the eect of serine mutations on the apoptotic activity of p53. Transfection of H1299 cells with 6 mg of wt hp53 plasmid DNA induced ecient apoptosis in H1299 cells (average 43%), whereas mutant p53Gln179 lacked this activity (average 4%). Transfection with p53all Ala induced an intermediate level of apoptosis (average 22%; Figure 3) . Analysis of each individual substitution mutant revealed that the substitutions of Ser 15 and 20 to alanines accounted for much of the reduction in the apoptotic activity of p53all Ala. Substitution of each of these residues reduced the apoptotic activity of p53 to approximately the same degree as mutating all six serine residues to alanine. Mutation of Ser 6, 9, 33 and 37 into Ala had little eect on the apoptotic activity of p53 (Figure 4) . These results support an important role for Ser 15 and 20 in mediating the apoptotic activity of p53.
Expression levels of p53 serine mutants
The ®ndings that p53Ala 15 and p53Ala 20 have impaired apoptotic activity raised the possibility that these substitutions cause a reduction in the expression level of p53 and consequently aect its ability to induce apoptosis. To test this possibility H1299 cells were transfected with wt p53 and the serine mutants using amounts of expression plasmids equivalent to those used in the apoptotic assay. Twenty-four hours posttransfection, cells were collected and the steady state levels of each p53 protein was determined by Western blot analysis. Figure 5a shows that the levels of p53 expression was comparable among the various mutants. In particular, the expression levels of p53Ala 15 was identical to that of wt p53 while p53Ala 20 had a slightly reduced expression (Figure 5a lanes 2 versus 5 and 6). This suggests that the impaired apoptotic activity of these two mutants is not due to reduced expression levels. The expression levels of these mutants was also compared at lower amount of expression plasmids (0.5 mg). Again the expression levels of these mutants was similar to that of wt p53 (Figure 5b) . Thus, the serine substitutions do not aect the levels of p53 expression under the experimental conditions used in the assays described here. This does Figure 3 p53all Ala is impaired in its ability to induce apoptosis. H1299 cells were transfected by the calcium phosphate coprecipitation method with the dierent p53 serine mutants (6 mg) and analysed 48 h later for cell cycle distribution by¯ow cytometry, employing staining of ®xed cells with propidium iodide Figure 4 A representative diagram of apoptotic activity induced by the serine substitution mutants of p53. H1299 cells were transfected with the dierent serine mutants (6 mg) and analysed for apoptosis activity as in Figure 3 not rule out that under dierent conditions such substitution would aect p53 expression. Discussion p53 undergoes phosphorylation on serine residues in its N-terminus in vitro and in vivo. However, the physiological role of these potential phosphorylation sites in the regulation of p53 functions is unclear. In this study we examined the eect of mutations of serine residues within the N-terminus of p53 on its biochemical and biological activities. The dierent serine mutants retain their sequence speci®c DNA binding ability, and in most cases their ability to transactivate physiological promoters was unaected. A slight reduction was observed, however, in the ability of p53Ala15 to induce the cyclin G promoter. This result is in accordance with previous ®ndings showing that substitution of Ser 15 to Ala reduces the ability of p53 to inhibit cell cycle progression (Fiscella et al., 1993) . Phosphorylation of Ser 15 results in the accumulation and activation of the p53 protein (Siliciano et al., 1997) . These eects are primarily due to the ability of this phosphorylation to neutralize the inhibitory eects of Mdm2 on p53 stability and activity (Shieh et al., 1997) .
The ability of serine mutants, including p53Ala 15, to suppress colony growth or cell transformation was roughly equal to that of wt p53. Both biological activities can be mediated, at least to some extent, by the induction of cell growth arrest. It is plausible that, under the experimental conditions used, the serine mutants induced growth arrest to a level that is sucient to suppress colony growth and cell transformation. These activities of p53 may be less sensitive to modulations by phosphorylation, at least in the assays used.
The most marked eect of the serine mutants was the reduction in the apoptotic activity of p53 in H1299 cells, which was mapped mainly to Ser 15 and Ser 20. The impairment of p53Ala 15 can be explained, at least in part, by the enhanced inhibitory eect of Mdm2 on the activity of p53Ala 15 . A similar explanation may account for the reduced activity of p53Ala 20. Indeed, our recent results suggest that the substitution of Ser 20 to Ala renders p53 more susceptible to inhibition by Mdm2 (T Unger, T Gershon-Juven, E Moallem, R Vogt Sionov, M Berger, M Oren, Y Haupt in preparation). It is noteworthy that Ser 20 resides within the Mdm2 binding site of p53 (residues 19 ± 26; Kussie et al., 1996 and references therein), and Ser 15 is adjacent to it. Thus phosphorylation of these residues may aect a b Figure 5 Expression levels of p53 serine mutants. H1299 cells were transfected with the indicated p53 serine mutants (3 mg of each expression plasmid in a and 0.3 mg in b). Twenty-four hours post-transfection cell extracts were prepared and subjected to Western blot analysis with a mixture of anti-p53 speci®c monoclonal antibodies (PAb1801+DO1). Equal loading was checked by probing the same blot with anti-actin (lower panels) the ability of Mdm2 to inhibit the biochemical and biological activities of p53 (Momand and Zambetti, 1997; Prives, 1998) and to promote its degradation (Haupt et al., 1997; Kubbutat et al., 1997) . Since the substitutions of Ser 15 and 20 to Ala did not alter p53 expression, under the experimental conditions used (Figure 5 ), it suggests that the impaired apoptotic activity was due to excessive susceptibility to inhibition by Mdm2.
While the modulation of Mdm2 interaction provides the most likely explanation for the impaired activity of p53Ala 20 and p53Ala 15, alternative possibilities cannot be ruled out. It was previously shown that p53 can induce apoptosis by a mechanism which is independent of transcriptional activation of target genes (reviewed in Vogt Sionov and Haupt, 1998) . Moreover, a truncated p53 molecule containing only the ®rst 214 amino acid residues (p53dl214) can induce apoptosis in certain cell types (Haupt et al., 1995) . It is conceivable that mutations in Ser 15 and 20, through changes in conformation and/or charge, may aect the relevant N-terminal apoptotic activity of p53. Serines 15 and 20 are also in the vicinity of the binding sites for other potential apoptosis promoting proteins such as p53BP2, for whose binding p53 competes with the Bcl-2 antiapoptotic protein (Naumovski and Cleary, 1996) . Further, the binding of p53 to several transcription factors, including the TATA binding protein and its associated factors, TAF31 and TAF70, may also be aected (Lu and Levine, 1995) . Finally, a role for transcriptional repression in the apoptotic function of p53 has been suggested (reviewed in Vogt Sionov and Haupt, 1998) . The ability of p53 to repress relevant genes such as bcl-2, IGF-I receptor and MAP4 (Miyashita et al., 1994; Murphy et al., 1996; Prisco et al., 1997) may be impaired by mutations in Ser 15 and 20.
Overall, our results do not support a role for Serines 6, 9, 33 and 37 in the regulation of various p53 activities. On the other hand, both Ser 15 and 20 appear to be important in regulating at least some activities of p53. Recently, Siliciano et al. (1997) described the phosphorylation of two serines within the ®rst 24 amino acid residues of p53 in response to ionizing and ultraviolet irradiation. Out of the four potential serines in this region (6, 9, 15 and 20) , only Ser 15 was identi®ed to be phosphorylated. The results presented here suggest that Ser 6 and 9 do not play a critical role in the regulation of p53 activity. By contrast, p53Ala 20 had impaired apoptotic activity, implicating phosphorylation of Ser 20 as an important regulatory mechanism. Thus, phosphorylation of p53 at Ser 15 and 20 can modulate its activity, thereby establishing a link between environmental stress signals, intracellular changes, and p53 activity.
Materials and methods
Cells and transfections
Mouse embryo ®broblasts were grown in DMEM, while H1299 and H358 cells were maintained in RPMI supplemented with 10% fetal calf serum and grown at 37.58C. H1299 and H358 cell lines are derived from human lung cancers and are devoid of any p53 expression. H358 cells were transfected using lipofectin (GIBCO BRL), while H1299 cells were transfected with the calcium phosphate coprecipitation procedure including a shock with 10% glycerol for 1 min. The exact amounts of plasmids used in each experiment are indicated in the corresponding ®gure legends. Whenever needed, empty vector DNA was used to maintain a constant amount of DNA in each transfection mix. In CAT assays a b-galactosidase expression plasmid, pCMVb (Clontech Laboratories) was included in each DNA mixture to monitor transfection eciency and to standardize the amounts of extract used. One-®fth of each extract was analysed for b-galactosidase activity. Luciferase assays were carried out as previously described .
REF were prepared and transfected as described previously (Unger et al., 1993) . p53 expression plasmids were analysed by focus formation assay in combination with either mutant ras plus adenovirus E1A or ras alone. Two weeks after transfection, the number of transformed foci was scored.
Inhibition of cellular growth was assayed for dierent p53 serine mutants by virtue of the fact that the expression plasmids also contained the neomycin gene. Thirty-six hours after transfection of H358 cells, cells were subjected to G418 selection (400 mg/ml). Three weeks later the colonies were ®xed, stained with Giemsa and counted. The ability to suppress G418 colony formation was compared to wt p53 and to the p53Gln179 mutant. Empty pRC/CMV vector was used as a control.
Western blot analysis was carried out as previously described (Haupt et al., 1995) . The antibodies used were: anti-human p53 monoclonal antibodies PAb1801, PAb421 and equal loading was checked by using anti-actin (Sigma).
Plasmids
All human p53 cDNA serine mutant constructs were generated by PCR-based oligonucleotide-directed mutagenesis. The serine sites at positions 4, 6, 9, 15, 20, 33 and 37 were each converted into alanine or to aspartate using speci®c oligonucleotides, or all the six serine residues were converted to alanine or aspartate. The resultant PCR products were cloned into the XbaI ± HindIII site of pRC/CMV (InVitrogen). The mutated plasmids were subjected to DNA sequencing to con®rm the desired mutation and to ensure that other mutations have not been introduced during the PCR.
All p53 cDNAs were expressed from the CMV immediateearly promoter. The dierent reporter constructs used for transactivation assays are: p6FSVCAT, which contains six tandem repeats of the p53 binding motif TGCCT upstream of the SV40 minimal promoter (Mietz et al., 1992) ; cyclin G luciferase, comprising two p53 binding sites and derived from the rat cyclin G gene (Zauberman et al., 1995) and bax luciferase, containing the proximal promoter region of the human bax gene (Miyashita and Reed, 1995) .
Electrophoretic mobility shift assay (EMSA)
H358 cells were transfected with the dierent serine mutant constructs (6 mg). Thirty-six hours post-transfection nuclear extracts were subjected to gel shift assay as previously described (Unger et al., 1993) . End-labeled double-stranded oligonucleotide p53 consensus sequence (p53 CON) was used as the probe (Funk et al., 1992) . About half the nuclear extract of each sample was incubated in the presence of p53 monoclonal antibody PAb1801 prior to binding with DNA. The binding assay was carried out at room temperature for 30 min, and the protein-DNA complexes were resolved on a 4% non denaturing polyacrylamide gels (16Tris-borate-EDTA).
Flow cytometry
Forty-eight hours post-transfection,¯oating and adherent cells were collected, ®xed, stained as described in . Samples were analysed by¯ow cytometry (FACSCalibur, Becton Dickinson). Transfected p53 was reacted with a mixture of the DO-1 and PAb1801 anti-p53 antibodies, followed by goat anti-mouse FITC-conjugated antibody (Jackson). Apoptotic cells were quanti®ed as the proportion of cells that contained DNA content of less than 2N (Sub-G1 DNA content) as previously described .
